As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world.

Dr. Khorvash determined computationally how an antibody specific towards Alzheimer's disease (AD) detects its toxic species, amyloid beta oligomers. The target regions were used to design a smaller version of the antibody and to predict the binding sites of oligomers on the surface of neurons, which can be used to design more effective antibodies.

A randomly-selected Doctoral citation each day: today from the Doctor of Philosophy in Experimental Medicine (PhD) - graduated in 2020